Life ScienceCompany
Enantigen Therapeutics Ownership
Who owns Enantigen Therapeutics?
Enantigen Therapeutics is owned by OnCore Biopharma. It was acquired on October 1, 2014.
Enantigen Therapeutics Business Overview
Where is Enantigen Therapeutics headquartered?
Enantigen Therapeutics is headquartered in Doylestown, Pennsylvania.
What sector is Enantigen Therapeutics in?
Enantigen Therapeutics is a life science company.
When was Enantigen Therapeutics founded?
Enantigen Therapeutics was founded in 2010.
Life Science M&A Summary in 2014
Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2014. The largest life science acquisition in 2014 was InterMune - which was acquired by Roche Holding AG for $8.3B.
Join Mergr to view all 237 acquisitions of life science companies in 2014, including 22 acquisitions by private equity firms, and 215 by strategics.